Literature DB >> 8277955

Care of patients with ascites.

B A Runyon1.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 8277955     DOI： 10.1056/NEJM199402033300508

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  77 in total

1.  Two cases of refractory ascites associated with dill pickle ingestion.

Authors:  T R Riley
Journal:  Dig Dis Sci       Date:  2000-06       Impact factor: 3.199

2.  Evaluation of New-Onset Ascites.

Authors:  Yuval A Patel; Andrew J Muir
Journal:  JAMA       Date:  2016-07-19       Impact factor: 56.272

3.  Malignant ascites: A review of prognostic factors, pathophysiology and therapeutic measures.

Authors:  Suma L Sangisetty; Thomas J Miner
Journal:  World J Gastrointest Surg       Date:  2012-04-27

4.  Predictors of large volume paracantesis induced circulatory dysfunction in patients with massive hepatic ascites.

Authors:  G Nasr; A Hassan; S Ahmed; A Serwah
Journal:  J Cardiovasc Dis Res       Date:  2010-07

5.  Value of combined detection of AFU and TCH in differential diagnosis between malignant and non-tuberculous benign ascites.

Authors:  Hong Zhang; Feng Li; Qun Wei; Yu-Fei Zhu
Journal:  Med Oncol       Date:  2010-11-02       Impact factor: 3.064

6.  Low gradient ascites: a seven-year course review.

Authors:  Fariborz Mansour-Ghanaei; Afshin Shafaghi; Amir-Hossein Bagherzadeh; Mohammad-Sadegh Fallah
Journal:  World J Gastroenterol       Date:  2005-04-21       Impact factor: 5.742

7.  Central venous pressure catheter for large-volume paracentesis in refractory ascites.

Authors:  Shahram Agah; Sahar Tavakoli; Hajar Nikbakht; Mehrdokht Najafi; Abdolreza Al-Agha
Journal:  Indian J Gastroenterol       Date:  2014-04-24

8.  Clinicopathological characteristics and prognosis of gastric cancer with malignant ascites.

Authors:  Nian Fang; Hui-Qing Zhang; Bo He; Mei Xie; Shan Lu; Yi-Ye Wan; Nong-Rong Wang
Journal:  Tumour Biol       Date:  2013-11-27

9.  Malignant Pleural Effusion and ascites Induce Epithelial-Mesenchymal Transition and Cancer Stem-like Cell Properties via the Vascular Endothelial Growth Factor (VEGF)/Phosphatidylinositol 3-Kinase (PI3K)/Akt/Mechanistic Target of Rapamycin (mTOR) Pathway.

Authors:  Tao Yin; Guoping Wang; Sisi He; Guobo Shen; Chao Su; Yan Zhang; Xiawei Wei; Tinghong Ye; Ling Li; Shengyong Yang; Dan Li; Fuchun Guo; Zeming Mo; Yang Wan; Ping Ai; Xiaojuan Zhou; Yantong Liu; Yongsheng Wang; Yuquan Wei
Journal:  J Biol Chem       Date:  2016-10-18       Impact factor: 5.157

Review 10.  Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research.

Authors:  Emma Kipps; David S P Tan; Stan B Kaye
Journal:  Nat Rev Cancer       Date:  2013-02-21       Impact factor: 60.716
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.